ID27153A - Senyawa inhibitor spla2 untuk mengobati penyakit - Google Patents

Senyawa inhibitor spla2 untuk mengobati penyakit

Info

Publication number
ID27153A
ID27153A IDW20002214A ID20002214A ID27153A ID 27153 A ID27153 A ID 27153A ID W20002214 A IDW20002214 A ID W20002214A ID 20002214 A ID20002214 A ID 20002214A ID 27153 A ID27153 A ID 27153A
Authority
ID
Indonesia
Prior art keywords
inhibitor compounds
treat disease
spla2 inhibitor
spla2
treat
Prior art date
Application number
IDW20002214A
Other languages
English (en)
Indonesian (id)
Inventor
William Louis Macias
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ID27153A publication Critical patent/ID27153A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/22—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an aralkyl radical attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IDW20002214A 1998-05-01 1999-04-20 Senyawa inhibitor spla2 untuk mengobati penyakit ID27153A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8387498P 1998-05-01 1998-05-01

Publications (1)

Publication Number Publication Date
ID27153A true ID27153A (id) 2001-03-08

Family

ID=22181224

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20002214A ID27153A (id) 1998-05-01 1999-04-20 Senyawa inhibitor spla2 untuk mengobati penyakit

Country Status (20)

Country Link
US (1) US6340699B1 (no)
EP (1) EP1084108A4 (no)
JP (1) JP2002513783A (no)
KR (1) KR20010043190A (no)
CN (1) CN1299348A (no)
AU (1) AU3656299A (no)
BR (1) BR9910095A (no)
CA (1) CA2330856A1 (no)
CZ (1) CZ20004052A3 (no)
EA (1) EA200001140A1 (no)
HR (1) HRP20000739A2 (no)
HU (1) HUP0102243A2 (no)
ID (1) ID27153A (no)
IL (1) IL139019A0 (no)
NO (1) NO20005479L (no)
PL (1) PL343708A1 (no)
SK (1) SK16342000A3 (no)
TR (1) TR200003194T2 (no)
WO (1) WO1999057100A1 (no)
ZA (1) ZA200005563B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19962300A1 (de) * 1999-12-23 2001-06-28 Asta Medica Ag Substituierte N-Benzyl-Indol-3-yl-glyoxylsäure-Derivate mit Antitumorwirkung
WO2001055108A2 (en) * 2000-01-25 2001-08-02 Eli Lilly And Company Use of spl a2 inhibitors for the treatment of inflammation
WO2002000621A1 (en) * 2000-06-29 2002-01-03 Shionogi & Co., Ltd. Compounds exhibiting x-type spla2 inhibiting effect
AU2453102A (en) * 2000-07-24 2002-02-05 Dow Global Technologies Inc Thermoplastic superabsorbent polymer blend compositions and their preparation
MX2008005664A (es) * 2005-11-03 2008-12-15 Ilypsa Inc Compuestos de indol que tienen sustituyentes c4-acidos y uso de los mismos como inhibidores de fosfolipasa a2.
CA2720275A1 (en) * 2008-04-01 2009-10-08 Astellas Pharma Inc. Indolinone compound
NZ624963A (en) 2009-04-29 2016-07-29 Amarin Pharmaceuticals Ie Ltd Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
US9290752B2 (en) 2013-03-13 2016-03-22 Sunny Delight Beverages Co. Process for enhancing the amylase inhibitory efficacy from phaseolus vulgaris extracts

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5356919A (en) 1991-05-30 1994-10-18 G. D. Searle & Co. Leukotriene B4 synthesis inhibitors
DE4218096A1 (de) 1992-06-02 1993-12-09 Boehringer Mannheim Gmbh Spiro-oxetane, Verfahren zu ihrer Herstellung und Arzneimittel
DE4323409A1 (de) 1993-07-13 1995-01-19 Boehringer Mannheim Gmbh Verwendung von Cumarinen und Carbostyrilen als PLA¶2¶-Inhibitoren, neue Cumarine und Carbostyrile, Verfahren zu ihrer Herstellung und Arzneimittel
BR9501404A (pt) * 1994-04-01 1996-03-05 Lilly Co Eli 1H-indol-3 glioxilamida e formulação farmacèutica
WO1995033462A1 (en) * 1994-06-02 1995-12-14 Smithkline Beecham Corporation Anti-inflammatory compounds
NZ298145A (en) * 1994-12-29 1998-08-26 Yamanouchi Pharma Co Ltd Monoclonal antibodies having inhibitory effect on type ii phospholipase a2, proteins forming part thereof, cells producing them, dna encoding them, recombinant vector comprising the dna and medicament
CA2269203A1 (en) 1996-10-30 1998-05-07 Nicholas James Bach Substituted tricyclics
EE200000488A (et) * 1998-02-25 2002-02-15 Genetics Institute, Inc. Fosfolipaasensüümide inhibiitorid ja farmatseutilised kompositsioonid

Also Published As

Publication number Publication date
EA200001140A1 (ru) 2001-04-23
WO1999057100A1 (en) 1999-11-11
IL139019A0 (en) 2001-11-25
HRP20000739A2 (en) 2001-10-31
TR200003194T2 (tr) 2001-03-21
EP1084108A1 (en) 2001-03-21
ZA200005563B (en) 2002-01-10
KR20010043190A (ko) 2001-05-25
SK16342000A3 (sk) 2002-04-04
BR9910095A (pt) 2000-12-26
NO20005479L (no) 2000-12-20
CN1299348A (zh) 2001-06-13
HUP0102243A2 (hu) 2001-10-28
AU3656299A (en) 1999-11-23
EP1084108A4 (en) 2005-01-12
NO20005479D0 (no) 2000-10-31
US6340699B1 (en) 2002-01-22
PL343708A1 (en) 2001-08-27
JP2002513783A (ja) 2002-05-14
CZ20004052A3 (cs) 2002-05-15
CA2330856A1 (en) 1999-11-11

Similar Documents

Publication Publication Date Title
PT1224195E (pt) C-aril-glicosidos inibidores de tgls2
DE69929020D1 (de) Rohrschuh
FI951553L (fi) 1H-indoli-glyoksyyliamidi-sPLA2-inhibiittoreita
CU23063A3 (es) Imidazotriazinonas 2-fenil sustituidas como inhibidores de fosfodiesterasas
AR028253A1 (es) Inhibidores de la glucogeno fosforilasa
NO20010760L (no) Griperenhet for brönntraktorer
NO20012995D0 (no) Forbindelse nyttige for behandling av inflammatoriske sykdommer
PT1181017E (pt) Inibidores de metaloproteases
LTC1124961I2 (lt) Trombopoetino junginiai
NO20016319D0 (no) VLA-4 inhibitor-forbindelser
ATE229954T1 (de) Betacarbolinverbindungen
ID28266A (id) Senyawa-senyawa amidin
BR0010080B1 (pt) inibidores de renina
NO20011745L (no) Forbindelser
PT1194404E (pt) Inibidores de aspartil-protease
ID27346A (id) Peralatan pengenal suara
NO20005006L (no) Kalsilytiske forbindelser
ID29966A (id) Sulfoniloksazolamina-sulfoniloksazolamina sebagai senyawa-senyawa aktif terapi
ATE252547T1 (de) Matrixmetalloproteinaseinhibitoren
NO20006662L (no) Fluorfenylresin-forbindelser
ID27153A (id) Senyawa inhibitor spla2 untuk mengobati penyakit
EP1093373A4 (en) OLIGONUCLEOTIDES INHIBITORS OF bcl-xL
ID28032A (id) TRISIKLIK PIPERIDIN-Δ3-SEBAGAI ANTAGONIS-α2
EP1025851A4 (en) alpha-GLUCOSIDASE HEMMER
PT1175417E (pt) Compostos substituidos de benzolactamas